,gene_id,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,length,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,Treatment_Compare
147,Mcavernosa13005,GO:0080144,0.005654587,1,1,1,amino acid homeostasis,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
148,Mcavernosa13005,GO:0080144,0.005654587,1,1,1,amino acid homeostasis,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
284,Mcavernosa20093,GO:0072488,0.019601482,0.999857102,1,4,ammonium transmembrane transport,BP,3467,234.587699,-0.762978102,0.192041569,-3.972984104,7.10E-05,0.0261073,CvsT2
101,Mcavernosa12043,GO:0097065,0.031983885,0.999563371,1,7,anterior head development,BP,1395,656.1566008,-1.845778008,0.359438644,-5.135168515,2.82E-07,0.000320485,CvsT2
102,Mcavernosa12043,GO:0097065,0.031983885,0.999563371,1,7,anterior head development,BP,1395,656.1566008,-1.980691766,0.359095716,-5.515776658,3.47E-08,6.33E-05,CvsT1
103,Mcavernosa12043,GO:0097065,0.031983885,0.999563371,1,7,anterior head development,BP,1395,656.1566008,-1.621453401,0.359545852,-4.509726351,6.49E-06,0.008349794,CvsT4
104,Mcavernosa12043,GO:0097065,0.031983885,0.999563371,1,7,anterior head development,BP,1395,656.1566008,-1.650718202,0.35952349,-4.591405705,4.40E-06,0.004011494,CvsT3
204,Mcavernosa15503,GO:0060928,0.009679747,0.999976847,1,2,atrioventricular node cell development,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
205,Mcavernosa15503,GO:0060928,0.009679747,0.999976847,1,2,atrioventricular node cell development,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
155,Mcavernosa13005,GO:0000422,0.024445749,0.99976253,1,5,autophagy of mitochondrion,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
156,Mcavernosa13005,GO:0000422,0.024445749,0.99976253,1,5,autophagy of mitochondrion,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
84,Mcavernosa03628,GO:0001782,0.026048226,0.999719039,1,6,B cell homeostasis,BP,1737,40.74486054,-3.563927207,0.791478035,-4.502875695,6.70E-06,0.006769312,CvsT1
85,Mcavernosa03628,GO:0001782,0.026048226,0.999719039,1,6,B cell homeostasis,BP,1737,40.74486054,-3.231938334,0.79422058,-4.069320809,4.72E-05,0.019021379,CvsT2
240,Mcavernosa15503,GO:0061312,0.009502871,0.999977688,1,2,BMP signaling pathway involved in heart development,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
241,Mcavernosa15503,GO:0061312,0.009502871,0.999977688,1,2,BMP signaling pathway involved in heart development,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
422,Mcavernosa33068,GO:0070509,0.043535909,0.999147195,1,10,calcium ion import,BP,1118,45.86133265,-1.046864772,0.262721652,-3.984691651,6.76E-05,0.0261073,CvsT2
212,Mcavernosa15503,GO:0003215,0.029716596,0.999633791,1,6,cardiac right ventricle morphogenesis,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
213,Mcavernosa15503,GO:0003215,0.029716596,0.999633791,1,6,cardiac right ventricle morphogenesis,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
214,Mcavernosa15503,GO:0001502,0.043304951,0.999156294,1,10,cartilage condensation,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
215,Mcavernosa15503,GO:0001502,0.043304951,0.999156294,1,10,cartilage condensation,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
358,Mcavernosa25973,GO:0071360,0.025118304,0.999749214,1,5,cellular response to exogenous dsRNA,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
359,Mcavernosa25973,GO:0071360,0.025118304,0.999749214,1,5,cellular response to exogenous dsRNA,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
109,Mcavernosa13005,GO:0071455,0.018665681,0.999870472,1,4,cellular response to hyperoxia,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
110,Mcavernosa13005,GO:0071455,0.018665681,0.999870472,1,4,cellular response to hyperoxia,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
117,Mcavernosa13005,GO:0071315,0.009650168,0.999976989,1,2,cellular response to morphine,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
118,Mcavernosa13005,GO:0071315,0.009650168,0.999976989,1,2,cellular response to morphine,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
26,Mcavernosa02339,GO:1990090,0.006368957,0.999773575,2,25,cellular response to nerve growth factor stimulus,BP,1231,129.019574,1.071517133,0.262199641,4.086646069,4.38E-05,0.018244336,CvsT2
383,Mcavernosa30410,GO:1990090,0.006368957,0.999773575,2,25,cellular response to nerve growth factor stimulus,BP,2360,67.87413264,-4.840038259,1.177933367,-4.108923639,3.98E-05,0.031070178,CvsT4
77,Mcavernosa03157,GO:0036120,0.043272832,0.999167818,1,9,cellular response to platelet-derived growth factor stimulus,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
59,Mcavernosa03157,GO:0071380,0.032553671,0.999547574,1,7,cellular response to prostaglandin E stimulus,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
121,Mcavernosa13005,GO:0034614,0.0323525,0.999553184,1,7,cellular response to reactive oxygen species,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
122,Mcavernosa13005,GO:0034614,0.0323525,0.999553184,1,7,cellular response to reactive oxygen species,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
141,Mcavernosa13005,GO:0090156,0.011406658,0.999967821,1,2,cellular sphingolipid homeostasis,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
142,Mcavernosa13005,GO:0090156,0.011406658,0.999967821,1,2,cellular sphingolipid homeostasis,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
151,Mcavernosa13005,GO:0021955,0.015510461,0.999920572,1,3,central nervous system neuron axonogenesis,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
152,Mcavernosa13005,GO:0021955,0.015510461,0.999920572,1,3,central nervous system neuron axonogenesis,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
105,Mcavernosa13005,GO:0021680,0.026704721,0.999704621,1,6,cerebellar Purkinje cell layer development,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
106,Mcavernosa13005,GO:0021680,0.026704721,0.999704621,1,6,cerebellar Purkinje cell layer development,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
133,Mcavernosa13005,GO:0061684,0.011025332,0.999969942,1,2,chaperone-mediated autophagy,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
134,Mcavernosa13005,GO:0061684,0.011025332,0.999969942,1,2,chaperone-mediated autophagy,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
60,Mcavernosa03157,GO:0007635,0.023269311,0.999784941,1,5,chemosensory behavior,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
52,Mcavernosa03157,GO:0040024,0.021352902,0.999819049,1,5,dauer larval development,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
69,Mcavernosa03157,GO:1990504,0.012706826,0.999946759,1,3,dense core granule exocytosis,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
374,Mcavernosa26093,GO:0015966,0.009090382,0.999979587,1,2,diadenosine tetraphosphate biosynthetic process,BP,3092,62.8032388,-2.078882671,0.433108098,-4.799916415,1.59E-06,0.001419634,CvsT2
375,Mcavernosa26093,GO:0015966,0.009090382,0.999979587,1,2,diadenosine tetraphosphate biosynthetic process,BP,3092,62.8032388,-2.005559371,0.432774224,-4.634193216,3.58E-06,0.003516066,CvsT3
376,Mcavernosa26093,GO:0015966,0.009090382,0.999979587,1,2,diadenosine tetraphosphate biosynthetic process,BP,3092,62.8032388,-2.065820478,0.431381371,-4.788849538,1.68E-06,0.002377438,CvsT1
210,Mcavernosa15503,GO:0035912,0.009898896,0.999975784,1,2,dorsal aorta morphogenesis,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
211,Mcavernosa15503,GO:0035912,0.009898896,0.999975784,1,2,dorsal aorta morphogenesis,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
330,Mcavernosa25973,GO:0033227,0.022817482,0.99979325,1,5,dsRNA transport,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
331,Mcavernosa25973,GO:0033227,0.022817482,0.99979325,1,5,dsRNA transport,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
250,Mcavernosa15503,GO:0007398,0.01918799,0.999863091,1,4,ectoderm development,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
251,Mcavernosa15503,GO:0007398,0.01918799,0.999863091,1,4,ectoderm development,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
404,Mcavernosa30572,GO:0022900,0.001919699,0.999964986,2,14,electron transport chain,BP,1005,80.83542411,2.536921528,0.426786258,5.944243711,2.78E-09,2.30E-05,CvsT4
405,Mcavernosa30572,GO:0022900,0.001919699,0.999964986,2,14,electron transport chain,BP,1005,80.83542411,2.621084843,0.42831687,6.11949944,9.39E-10,1.71E-06,CvsT3
406,Mcavernosa30572,GO:0022900,0.001919699,0.999964986,2,14,electron transport chain,BP,1005,80.83542411,2.52336795,0.428497658,5.888872207,3.89E-09,1.34E-05,CvsT2
407,Mcavernosa30572,GO:0022900,0.001919699,0.999964986,2,14,electron transport chain,BP,1005,80.83542411,2.454734168,0.424001941,5.789440873,7.06E-09,1.50E-05,CvsT1
408,Mcavernosa30573,GO:0022900,0.001919699,0.999964986,2,14,electron transport chain,BP,849,48.37751756,2.429376336,0.425734667,5.706315517,1.15E-08,2.41E-05,CvsT2
409,Mcavernosa30573,GO:0022900,0.001919699,0.999964986,2,14,electron transport chain,BP,849,48.37751756,2.642152981,0.425552326,6.208761701,5.34E-10,1.36E-06,CvsT1
410,Mcavernosa30573,GO:0022900,0.001919699,0.999964986,2,14,electron transport chain,BP,849,48.37751756,1.877006536,0.410691899,4.570351982,4.87E-06,0.007611554,CvsT4
411,Mcavernosa30573,GO:0022900,0.001919699,0.999964986,2,14,electron transport chain,BP,849,48.37751756,2.621605005,0.428284154,6.121181425,9.29E-10,1.71E-06,CvsT3
248,Mcavernosa15503,GO:0003272,0.010683252,0.999971784,1,2,endocardial cushion formation,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
249,Mcavernosa15503,GO:0003272,0.010683252,0.999971784,1,2,endocardial cushion formation,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
246,Mcavernosa15503,GO:0060350,0.018251139,0.999876184,1,4,endochondral bone morphogenesis,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
247,Mcavernosa15503,GO:0060350,0.018251139,0.999876184,1,4,endochondral bone morphogenesis,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
34,Mcavernosa02339,GO:0099638,0.010266755,0.999973946,1,2,endosome to plasma membrane protein transport,BP,1231,129.019574,1.071517133,0.262199641,4.086646069,4.38E-05,0.018244336,CvsT2
309,Mcavernosa24806,GO:0061028,0.021079837,0.999823668,1,5,establishment of endothelial barrier,BP,4855,1104.845015,-0.991656755,0.260593418,-3.805379137,0.000141587,0.041178809,CvsT2
27,Mcavernosa02339,GO:0001770,0.005106591,1,1,1,establishment of natural killer cell polarity,BP,1231,129.019574,1.071517133,0.262199641,4.086646069,4.38E-05,0.018244336,CvsT2
220,Mcavernosa15503,GO:0006703,0.020076201,0.999850066,1,4,estrogen biosynthetic process,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
221,Mcavernosa15503,GO:0006703,0.020076201,0.999850066,1,4,estrogen biosynthetic process,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
354,Mcavernosa25973,GO:0022617,0.036526514,0.999429509,1,7,extracellular matrix disassembly,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
355,Mcavernosa25973,GO:0022617,0.036526514,0.999429509,1,7,extracellular matrix disassembly,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
93,Mcavernosa09510,GO:0048592,0.000512722,0.99999584,2,7,eye morphogenesis,BP,1733,62.57618856,-1.087361575,0.27891717,-3.898510714,9.68E-05,0.047484759,CvsT3
289,Mcavernosa21617,GO:0048592,0.000512722,0.99999584,2,7,eye morphogenesis,BP,420,125.7549327,1.018044844,0.266038833,3.826677608,0.000129884,0.0402567,CvsT2
46,Mcavernosa03157,GO:0038096,0.014184481,0.999933612,1,3,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
202,Mcavernosa15503,GO:1905285,0.005289377,1,1,1,fibrous ring of heart morphogenesis,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
203,Mcavernosa15503,GO:1905285,0.005289377,1,1,1,fibrous ring of heart morphogenesis,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
295,Mcavernosa24249,GO:0006071,0.031802858,0.999568331,1,7,glycerol metabolic process,BP,1319,69.55413765,-3.986139509,0.922782607,-4.319695105,1.56E-05,0.015242565,CvsT4
298,Mcavernosa24249,GO:0046167,0.00504164,1,1,1,glycerol-3-phosphate biosynthetic process,BP,1319,69.55413765,-3.986139509,0.922782607,-4.319695105,1.56E-05,0.015242565,CvsT4
25,Mcavernosa01732,GO:0006544,0.018851804,0.999867866,1,4,glycine metabolic process,BP,4318,117.0658373,-1.794675121,0.434206367,-4.13323078,3.58E-05,0.015425471,CvsT2
368,Mcavernosa26093,GO:0006426,0.00377484,1,1,1,glycyl-tRNA aminoacylation,BP,3092,62.8032388,-2.078882671,0.433108098,-4.799916415,1.59E-06,0.001419634,CvsT2
369,Mcavernosa26093,GO:0006426,0.00377484,1,1,1,glycyl-tRNA aminoacylation,BP,3092,62.8032388,-2.005559371,0.432774224,-4.634193216,3.58E-06,0.003516066,CvsT3
370,Mcavernosa26093,GO:0006426,0.00377484,1,1,1,glycyl-tRNA aminoacylation,BP,3092,62.8032388,-2.065820478,0.431381371,-4.788849538,1.68E-06,0.002377438,CvsT1
176,Mcavernosa15503,GO:0060914,0.020112146,0.999849526,1,4,heart formation,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
177,Mcavernosa15503,GO:0060914,0.020112146,0.999849526,1,4,heart formation,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
188,Mcavernosa15503,GO:0035137,0.023531025,0.999780053,1,5,hindlimb morphogenesis,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
189,Mcavernosa15503,GO:0035137,0.023531025,0.999780053,1,5,hindlimb morphogenesis,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
421,Mcavernosa33068,GO:0099703,0.010251631,0.999974023,1,2,induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration,BP,1118,45.86133265,-1.046864772,0.262721652,-3.984691651,6.76E-05,0.0261073,CvsT2
70,Mcavernosa03157,GO:0048009,0.021801135,0.999811338,1,5,insulin-like growth factor receptor signaling pathway,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
285,Mcavernosa20093,GO:0010102,0.003669778,1,1,1,lateral root morphogenesis,BP,3467,234.587699,-0.762978102,0.192041569,-3.972984104,7.10E-05,0.0261073,CvsT2
55,Mcavernosa03157,GO:0031663,0.023025443,0.999789447,1,5,lipopolysaccharide-mediated signaling pathway,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
45,Mcavernosa03157,GO:0002281,0.022248911,0.999803472,1,5,macrophage activation involved in immune response,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
80,Mcavernosa03628,GO:0002315,0.013569657,0.999939259,1,3,marginal zone B cell differentiation,BP,1737,40.74486054,-3.563927207,0.791478035,-4.502875695,6.70E-06,0.006769312,CvsT1
81,Mcavernosa03628,GO:0002315,0.013569657,0.999939259,1,3,marginal zone B cell differentiation,BP,1737,40.74486054,-3.231938334,0.79422058,-4.069320809,4.72E-05,0.019021379,CvsT2
208,Mcavernosa15503,GO:0048382,0.023890922,0.999773239,1,5,mesendoderm development,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
209,Mcavernosa15503,GO:0048382,0.023890922,0.999773239,1,5,mesendoderm development,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
226,Mcavernosa15503,GO:0003183,0.015257808,0.999923147,1,3,mitral valve morphogenesis,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
227,Mcavernosa15503,GO:0003183,0.015257808,0.999923147,1,3,mitral valve morphogenesis,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
166,Mcavernosa15503,GO:0001880,0.010454942,0.99997298,1,2,Mullerian duct regression,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
167,Mcavernosa15503,GO:0001880,0.010454942,0.99997298,1,2,Mullerian duct regression,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
311,Mcavernosa24806,GO:0016203,0.016953688,0.999893221,1,4,muscle attachment,BP,4855,1104.845015,-0.991656755,0.260593418,-3.805379137,0.000141587,0.041178809,CvsT2
264,Mcavernosa15503,GO:1902731,0.009746732,0.999976525,1,2,negative regulation of chondrocyte proliferation,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
265,Mcavernosa15503,GO:1902731,0.009746732,0.999976525,1,2,negative regulation of chondrocyte proliferation,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
153,Mcavernosa13005,GO:2000619,0.005654587,1,1,1,negative regulation of histone H4-K16 acetylation,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
154,Mcavernosa13005,GO:2000619,0.005654587,1,1,1,negative regulation of histone H4-K16 acetylation,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
31,Mcavernosa02339,GO:1903609,0.009151091,0.999979313,1,2,negative regulation of inward rectifier potassium channel activity,BP,1231,129.019574,1.071517133,0.262199641,4.086646069,4.38E-05,0.018244336,CvsT2
53,Mcavernosa03157,GO:0051562,0.012706826,0.999946759,1,3,negative regulation of mitochondrial calcium ion concentration,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
157,Mcavernosa13005,GO:0090298,0.005654587,1,1,1,negative regulation of mitochondrial DNA replication,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
158,Mcavernosa13005,GO:0090298,0.005654587,1,1,1,negative regulation of mitochondrial DNA replication,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
65,Mcavernosa03157,GO:0010917,0.026092869,0.999718071,1,6,negative regulation of mitochondrial membrane potential,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
234,Mcavernosa15503,GO:0051148,0.015343969,0.999922274,1,3,negative regulation of muscle cell differentiation,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
235,Mcavernosa15503,GO:0051148,0.015343969,0.999922274,1,3,negative regulation of muscle cell differentiation,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
119,Mcavernosa13005,GO:1903204,0.034494398,0.999491631,1,7,negative regulation of oxidative stress-induced neuron death,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
120,Mcavernosa13005,GO:1903204,0.034494398,0.999491631,1,7,negative regulation of oxidative stress-induced neuron death,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
66,Mcavernosa03157,GO:0051280,0.012706826,0.999946759,1,3,negative regulation of release of sequestered calcium ion into cytosol,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
72,Mcavernosa03157,GO:2001024,0.012706826,0.999946759,1,3,negative regulation of response to drug,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
198,Mcavernosa15503,GO:0014912,0.019935896,0.999852163,1,4,negative regulation of smooth muscle cell migration,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
199,Mcavernosa15503,GO:0014912,0.019935896,0.999852163,1,4,negative regulation of smooth muscle cell migration,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
51,Mcavernosa03157,GO:2000650,0.012856776,0.999945491,1,3,negative regulation of sodium ion transmembrane transporter activity,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
145,Mcavernosa13005,GO:0090155,0.005654587,1,1,1,negative regulation of sphingolipid biosynthetic process,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
146,Mcavernosa13005,GO:0090155,0.005654587,1,1,1,negative regulation of sphingolipid biosynthetic process,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
107,Mcavernosa13005,GO:0039689,0.005654587,1,1,1,negative stranded viral RNA replication,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
108,Mcavernosa13005,GO:0039689,0.005654587,1,1,1,negative stranded viral RNA replication,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
313,Mcavernosa24806,GO:0038180,0.018529139,0.999872368,1,4,nerve growth factor signaling pathway,BP,4855,1104.845015,-0.991656755,0.260593418,-3.805379137,0.000141587,0.041178809,CvsT2
115,Mcavernosa13005,GO:0050877,0.027694513,0.997800457,2,54,nervous system process,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
116,Mcavernosa13005,GO:0050877,0.027694513,0.997800457,2,54,nervous system process,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
287,Mcavernosa21617,GO:0050877,0.027694513,0.997800457,2,54,nervous system process,BP,420,125.7549327,1.018044844,0.266038833,3.826677608,0.000129884,0.0402567,CvsT2
89,Mcavernosa08717,GO:0014032,0.001144569,0.999984772,2,10,neural crest cell development,BP,1808,67.92137531,-1.411252966,0.312234498,-4.519849582,6.19E-06,0.006769312,CvsT1
90,Mcavernosa08717,GO:0014032,0.001144569,0.999984772,2,10,neural crest cell development,BP,1808,67.92137531,-1.323861668,0.314379182,-4.211034769,2.54E-05,0.016213107,CvsT3
91,Mcavernosa08717,GO:0014032,0.001144569,0.999984772,2,10,neural crest cell development,BP,1808,67.92137531,-1.43965391,0.314293684,-4.580600829,4.64E-06,0.003623942,CvsT2
218,Mcavernosa15503,GO:0014032,0.001144569,0.999984772,2,10,neural crest cell development,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
219,Mcavernosa15503,GO:0014032,0.001144569,0.999984772,2,10,neural crest cell development,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
260,Mcavernosa15503,GO:0021998,0.005289377,1,1,1,neural plate mediolateral regionalization,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
261,Mcavernosa15503,GO:0021998,0.005289377,1,1,1,neural plate mediolateral regionalization,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
396,Mcavernosa30571,GO:0006807,0.017626361,0.998905622,2,44,nitrogen compound metabolic process,BP,684,48.83118655,4.512290209,0.623908042,7.232300119,4.75E-13,2.02E-09,CvsT1
397,Mcavernosa30571,GO:0006807,0.017626361,0.998905622,2,44,nitrogen compound metabolic process,BP,684,48.83118655,3.292573354,0.586079945,5.617959429,1.93E-08,3.45E-05,CvsT2
398,Mcavernosa30571,GO:0006807,0.017626361,0.998905622,2,44,nitrogen compound metabolic process,BP,684,48.83118655,3.02436151,0.576772448,5.243595667,1.57E-07,0.000328235,CvsT4
399,Mcavernosa30571,GO:0006807,0.017626361,0.998905622,2,44,nitrogen compound metabolic process,BP,684,48.83118655,3.975067304,0.605057227,6.56973775,5.04E-11,1.61E-07,CvsT3
416,Mcavernosa30575,GO:0006807,0.017626361,0.998905622,2,44,nitrogen compound metabolic process,BP,519,43.9545456,3.351164074,0.570680152,5.872228186,4.30E-09,1.34E-05,CvsT2
417,Mcavernosa30575,GO:0006807,0.017626361,0.998905622,2,44,nitrogen compound metabolic process,BP,519,43.9545456,3.080140443,0.559759565,5.502613324,3.74E-08,0.000116994,CvsT4
418,Mcavernosa30575,GO:0006807,0.017626361,0.998905622,2,44,nitrogen compound metabolic process,BP,519,43.9545456,4.207624689,0.601279927,6.997780064,2.60E-12,3.09E-08,CvsT3
419,Mcavernosa30575,GO:0006807,0.017626361,0.998905622,2,44,nitrogen compound metabolic process,BP,519,43.9545456,4.506256497,0.611003547,7.375172399,1.64E-13,1.46E-09,CvsT1
254,Mcavernosa15503,GO:0001550,0.005289377,1,1,1,ovarian cumulus expansion,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
255,Mcavernosa15503,GO:0001550,0.005289377,1,1,1,ovarian cumulus expansion,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
37,Mcavernosa02620,GO:0018991,0.029098814,0.999648946,1,6,oviposition,BP,1458,23.01444182,-2.782782023,0.610643265,-4.557132098,5.19E-06,0.003814831,CvsT2
238,Mcavernosa15503,GO:0048352,0.005289377,1,1,1,paraxial mesoderm structural organization,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
239,Mcavernosa15503,GO:0048352,0.005289377,1,1,1,paraxial mesoderm structural organization,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
262,Mcavernosa15503,GO:0061626,0.014362501,0.999931929,1,3,pharyngeal arch artery morphogenesis,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
263,Mcavernosa15503,GO:0061626,0.014362501,0.999931929,1,3,pharyngeal arch artery morphogenesis,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
190,Mcavernosa15503,GO:0021983,0.040156638,0.999295272,1,8,pituitary gland development,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
191,Mcavernosa15503,GO:0021983,0.040156638,0.999295272,1,8,pituitary gland development,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
364,Mcavernosa25973,GO:0044854,0.005284331,1,1,1,plasma membrane raft assembly,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
365,Mcavernosa25973,GO:0044854,0.005284331,1,1,1,plasma membrane raft assembly,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
125,Mcavernosa13005,GO:0075044,0.010771441,0.999971315,1,2,positive regulation by symbiont of host autophagy,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
126,Mcavernosa13005,GO:0075044,0.010771441,0.999971315,1,2,positive regulation by symbiont of host autophagy,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
33,Mcavernosa02339,GO:1904719,0.005106591,1,1,1,positive regulation of AMPA glutamate receptor clustering,BP,1231,129.019574,1.071517133,0.262199641,4.086646069,4.38E-05,0.018244336,CvsT2
170,Mcavernosa15503,GO:1904414,0.005289377,1,1,1,positive regulation of cardiac ventricle development,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
171,Mcavernosa15503,GO:1904414,0.005289377,1,1,1,positive regulation of cardiac ventricle development,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
340,Mcavernosa25973,GO:0060355,0.019442068,0.999859426,1,4,positive regulation of cell adhesion molecule production,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
341,Mcavernosa25973,GO:0060355,0.019442068,0.999859426,1,4,positive regulation of cell adhesion molecule production,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
328,Mcavernosa25973,GO:1901890,0.009954662,0.99997551,1,2,positive regulation of cell junction assembly,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
329,Mcavernosa25973,GO:1901890,0.009954662,0.99997551,1,2,positive regulation of cell junction assembly,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
362,Mcavernosa25973,GO:2000049,0.020297038,0.999846734,1,4,positive regulation of cell-cell adhesion mediated by cadherin,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
363,Mcavernosa25973,GO:2000049,0.020297038,0.999846734,1,4,positive regulation of cell-cell adhesion mediated by cadherin,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
75,Mcavernosa03157,GO:0010811,0.035030598,0.999475592,1,7,positive regulation of cell-substrate adhesion,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
76,Mcavernosa03157,GO:2001031,0.009110924,0.999979495,1,2,positive regulation of cellular glucuronidation,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
200,Mcavernosa15503,GO:0032332,0.018036683,0.999879088,1,4,positive regulation of chondrocyte differentiation,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
201,Mcavernosa15503,GO:0032332,0.018036683,0.999879088,1,4,positive regulation of chondrocyte differentiation,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
54,Mcavernosa03157,GO:0010634,0.005596614,0.999813865,2,25,positive regulation of epithelial cell migration,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
165,Mcavernosa15302,GO:0010634,0.005596614,0.999813865,2,25,positive regulation of epithelial cell migration,BP,666,426.2322626,-5.344808043,1.281647396,-4.170264038,3.04E-05,0.01764079,CvsT3
216,Mcavernosa15503,GO:1902043,0.01099736,0.999970095,1,2,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
217,Mcavernosa15503,GO:1902043,0.01099736,0.999970095,1,2,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
78,Mcavernosa03628,GO:0043547,0.013626736,0.999265012,2,38,positive regulation of GTPase activity,BP,1737,40.74486054,-3.563927207,0.791478035,-4.502875695,6.70E-06,0.006769312,CvsT1
79,Mcavernosa03628,GO:0043547,0.013626736,0.999265012,2,38,positive regulation of GTPase activity,BP,1737,40.74486054,-3.231938334,0.79422058,-4.069320809,4.72E-05,0.019021379,CvsT2
312,Mcavernosa24806,GO:0043547,0.013626736,0.999265012,2,38,positive regulation of GTPase activity,BP,4855,1104.845015,-0.991656755,0.260593418,-3.805379137,0.000141587,0.041178809,CvsT2
336,Mcavernosa25973,GO:0034116,0.009416404,0.999978093,1,2,positive regulation of heterotypic cell-cell adhesion,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
337,Mcavernosa25973,GO:0034116,0.009416404,0.999978093,1,2,positive regulation of heterotypic cell-cell adhesion,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
71,Mcavernosa03157,GO:0050996,0.009110924,0.999979495,1,2,positive regulation of lipid catabolic process,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
44,Mcavernosa03157,GO:0070257,7.15E-05,0.999999886,2,3,positive regulation of mucus secretion,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
113,Mcavernosa13005,GO:0070257,7.15E-05,0.999999886,2,3,positive regulation of mucus secretion,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
114,Mcavernosa13005,GO:0070257,7.15E-05,0.999999886,2,3,positive regulation of mucus secretion,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
324,Mcavernosa25973,GO:1901741,0.013201201,0.999942523,1,3,positive regulation of myoblast fusion,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
325,Mcavernosa25973,GO:1901741,0.013201201,0.999942523,1,3,positive regulation of myoblast fusion,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
97,Mcavernosa12043,GO:0010976,0.032260528,0.99721396,2,58,positive regulation of neuron projection development,BP,1395,656.1566008,-1.845778008,0.359438644,-5.135168515,2.82E-07,0.000320485,CvsT2
98,Mcavernosa12043,GO:0010976,0.032260528,0.99721396,2,58,positive regulation of neuron projection development,BP,1395,656.1566008,-1.980691766,0.359095716,-5.515776658,3.47E-08,6.33E-05,CvsT1
99,Mcavernosa12043,GO:0010976,0.032260528,0.99721396,2,58,positive regulation of neuron projection development,BP,1395,656.1566008,-1.621453401,0.359545852,-4.509726351,6.49E-06,0.008349794,CvsT4
100,Mcavernosa12043,GO:0010976,0.032260528,0.99721396,2,58,positive regulation of neuron projection development,BP,1395,656.1566008,-1.650718202,0.35952349,-4.591405705,4.40E-06,0.004011494,CvsT3
305,Mcavernosa24806,GO:0010976,0.032260528,0.99721396,2,58,positive regulation of neuron projection development,BP,4855,1104.845015,-0.991656755,0.260593418,-3.805379137,0.000141587,0.041178809,CvsT2
180,Mcavernosa15503,GO:0010862,0.04356632,0.999145994,1,10,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
181,Mcavernosa15503,GO:0010862,0.04356632,0.999145994,1,10,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
302,Mcavernosa24806,GO:0045937,0.007668244,0.999985485,1,2,positive regulation of phosphate metabolic process,BP,4855,1104.845015,-0.991656755,0.260593418,-3.805379137,0.000141587,0.041178809,CvsT2
56,Mcavernosa03157,GO:0050927,0.016411549,0.999899964,1,4,positive regulation of positive chemotaxis,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
186,Mcavernosa15503,GO:1902895,0.041691004,0.99922802,1,9,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
187,Mcavernosa15503,GO:1902895,0.041691004,0.99922802,1,9,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
230,Mcavernosa15503,GO:0071902,0.024758684,0.999746301,1,6,positive regulation of protein serine/threonine kinase activity,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
231,Mcavernosa15503,GO:0071902,0.024758684,0.999746301,1,6,positive regulation of protein serine/threonine kinase activity,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
271,Mcavernosa18547,GO:0035025,0.033433478,0.999522622,1,7,positive regulation of Rho protein signal transduction,BP,2125,136.6696901,-2.18273819,0.424178073,-5.145806276,2.66E-07,0.000320485,CvsT2
272,Mcavernosa18547,GO:0035025,0.033433478,0.999522622,1,7,positive regulation of Rho protein signal transduction,BP,2125,136.6696901,-2.479373075,0.422286214,-5.871309529,4.32E-09,2.30E-05,CvsT4
273,Mcavernosa18547,GO:0035025,0.033433478,0.999522622,1,7,positive regulation of Rho protein signal transduction,BP,2125,136.6696901,-2.295514097,0.422600061,-5.431883025,5.58E-08,8.89E-05,CvsT1
274,Mcavernosa18547,GO:0035025,0.033433478,0.999522622,1,7,positive regulation of Rho protein signal transduction,BP,2125,136.6696901,-2.68666738,0.421568034,-6.37303392,1.85E-10,4.73E-07,CvsT3
366,Mcavernosa25973,GO:0048643,0.019897887,0.999852729,1,4,positive regulation of skeletal muscle tissue development,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
367,Mcavernosa25973,GO:0048643,0.019897887,0.999852729,1,4,positive regulation of skeletal muscle tissue development,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
206,Mcavernosa15503,GO:0060391,0.027745706,0.99968101,1,6,positive regulation of SMAD protein signal transduction,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
207,Mcavernosa15503,GO:0060391,0.027745706,0.99968101,1,6,positive regulation of SMAD protein signal transduction,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
322,Mcavernosa25973,GO:0032226,0.00902976,0.999979859,1,2,"positive regulation of synaptic transmission, dopaminergic",BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
323,Mcavernosa25973,GO:0032226,0.00902976,0.999979859,1,2,"positive regulation of synaptic transmission, dopaminergic",BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
61,Mcavernosa03157,GO:0032230,0.047755981,0.998972185,1,10,"positive regulation of synaptic transmission, GABAergic",BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
348,Mcavernosa25973,GO:0034141,0.009328119,0.999978503,1,2,positive regulation of toll-like receptor 3 signaling pathway,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
349,Mcavernosa25973,GO:0034141,0.009328119,0.999978503,1,2,positive regulation of toll-like receptor 3 signaling pathway,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
182,Mcavernosa15503,GO:0032915,0.005289377,1,1,1,positive regulation of transforming growth factor beta2 production,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
183,Mcavernosa15503,GO:0032915,0.005289377,1,1,1,positive regulation of transforming growth factor beta2 production,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
172,Mcavernosa15503,GO:1904707,0.046221738,0.999049444,1,9,positive regulation of vascular smooth muscle cell proliferation,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
173,Mcavernosa15503,GO:1904707,0.046221738,0.999049444,1,9,positive regulation of vascular smooth muscle cell proliferation,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
48,Mcavernosa03157,GO:0090303,0.038440499,0.999354653,1,8,positive regulation of wound healing,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
293,Mcavernosa22344,GO:0010499,0.016437567,0.999899646,1,4,proteasomal ubiquitin-independent protein catabolic process,BP,2456,180.7912741,-4.008289508,0.938384448,-4.271479047,1.94E-05,0.017345891,CvsT4
346,Mcavernosa25973,GO:0070528,0.02815273,0.999671528,1,6,protein kinase C signaling,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
347,Mcavernosa25973,GO:0070528,0.02815273,0.999671528,1,6,protein kinase C signaling,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
123,Mcavernosa13005,GO:0006497,0.021325233,0.999830738,1,4,protein lipidation,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
124,Mcavernosa13005,GO:0006497,0.021325233,0.999830738,1,4,protein lipidation,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
381,Mcavernosa30410,GO:0036010,0.023811038,0.999774761,1,5,protein localization to endosome,BP,2360,67.87413264,-4.840038259,1.177933367,-4.108923639,3.98E-05,0.031070178,CvsT4
360,Mcavernosa25973,GO:1903044,0.019942825,0.99985206,1,4,protein localization to membrane raft,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
361,Mcavernosa25973,GO:1903044,0.019942825,0.99985206,1,4,protein localization to membrane raft,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
316,Mcavernosa25968,GO:0097428,0.024796912,0.999755623,1,5,protein maturation by iron-sulfur cluster transfer,BP,330,232.260006,-3.394989178,0.698041114,-4.863594866,1.15E-06,0.001201334,CvsT2
86,Mcavernosa08717,GO:0006513,0.047496768,0.998973298,1,11,protein monoubiquitination,BP,1808,67.92137531,-1.411252966,0.312234498,-4.519849582,6.19E-06,0.006769312,CvsT1
87,Mcavernosa08717,GO:0006513,0.047496768,0.998973298,1,11,protein monoubiquitination,BP,1808,67.92137531,-1.323861668,0.314379182,-4.211034769,2.54E-05,0.016213107,CvsT3
88,Mcavernosa08717,GO:0006513,0.047496768,0.998973298,1,11,protein monoubiquitination,BP,1808,67.92137531,-1.43965391,0.314293684,-4.580600829,4.64E-06,0.003623942,CvsT2
168,Mcavernosa15503,GO:0030166,0.034080184,0.999493618,1,8,proteoglycan biosynthetic process,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
169,Mcavernosa15503,GO:0030166,0.034080184,0.999493618,1,8,proteoglycan biosynthetic process,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
149,Mcavernosa13005,GO:0021860,0.024419533,0.999763042,1,5,pyramidal neuron development,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
150,Mcavernosa13005,GO:0021860,0.024419533,0.999763042,1,5,pyramidal neuron development,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
303,Mcavernosa24806,GO:0032486,0.007407729,0.999986456,1,2,Rap protein signal transduction,BP,4855,1104.845015,-0.991656755,0.260593418,-3.805379137,0.000141587,0.041178809,CvsT2
111,Mcavernosa13005,GO:0060284,0.043690888,0.999151524,1,9,regulation of cell development,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
112,Mcavernosa13005,GO:0060284,0.043690888,0.999151524,1,9,regulation of cell development,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
304,Mcavernosa24806,GO:1901888,0.011237536,0.999958388,1,3,regulation of cell junction assembly,BP,4855,1104.845015,-0.991656755,0.260593418,-3.805379137,0.000141587,0.041178809,CvsT2
224,Mcavernosa15503,GO:2000772,0.010394311,0.999973293,1,2,regulation of cellular senescence,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
225,Mcavernosa15503,GO:2000772,0.010394311,0.999973293,1,2,regulation of cellular senescence,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
127,Mcavernosa13005,GO:1903706,0.022135443,0.999817569,1,4,regulation of hemopoiesis,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
128,Mcavernosa13005,GO:1903706,0.022135443,0.999817569,1,4,regulation of hemopoiesis,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
242,Mcavernosa15503,GO:0048378,0.025614247,0.99973916,1,5,regulation of lateral mesodermal cell fate specification,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
243,Mcavernosa15503,GO:0048378,0.025614247,0.99973916,1,5,regulation of lateral mesodermal cell fate specification,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
350,Mcavernosa25973,GO:0051580,0.009300416,0.999978631,1,2,regulation of neurotransmitter uptake,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
351,Mcavernosa25973,GO:0051580,0.009300416,0.999978631,1,2,regulation of neurotransmitter uptake,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
58,Mcavernosa03157,GO:0050730,0.022968759,0.999790487,1,5,regulation of peptidyl-tyrosine phosphorylation,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
307,Mcavernosa24806,GO:0071900,0.013966092,0.999935647,1,3,regulation of protein serine/threonine kinase activity,BP,4855,1104.845015,-0.991656755,0.260593418,-3.805379137,0.000141587,0.041178809,CvsT2
131,Mcavernosa13005,GO:0031396,0.038019541,0.999368814,1,8,regulation of protein ubiquitination,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
132,Mcavernosa13005,GO:0031396,0.038019541,0.999368814,1,8,regulation of protein ubiquitination,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
338,Mcavernosa25973,GO:0002090,0.029506907,0.999628746,1,7,regulation of receptor internalization,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
339,Mcavernosa25973,GO:0002090,0.029506907,0.999628746,1,7,regulation of receptor internalization,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
332,Mcavernosa25973,GO:0035023,0.010385489,0.999973339,1,2,regulation of Rho protein signal transduction,BP,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
333,Mcavernosa25973,GO:0035023,0.010385489,0.999973339,1,2,regulation of Rho protein signal transduction,BP,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
143,Mcavernosa13005,GO:1902617,0.010614114,0.999972149,1,2,response to fluoride,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
144,Mcavernosa13005,GO:1902617,0.010614114,0.999972149,1,2,response to fluoride,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
29,Mcavernosa02339,GO:1904313,0.008770611,0.999981001,1,2,response to methamphetamine hydrochloride,BP,1231,129.019574,1.071517133,0.262199641,4.086646069,4.38E-05,0.018244336,CvsT2
74,Mcavernosa03157,GO:1902074,0.028231322,0.999669681,1,6,response to salt,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
94,Mcavernosa09510,GO:0009411,0.049569621,0.99889186,1,10,response to UV,BP,1733,62.57618856,-1.087361575,0.27891717,-3.898510714,9.68E-05,0.047484759,CvsT3
232,Mcavernosa15503,GO:0060041,0.012608109,0.999348519,2,36,retina development in camera-type eye,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
233,Mcavernosa15503,GO:0060041,0.012608109,0.999348519,2,36,retina development in camera-type eye,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
286,Mcavernosa21617,GO:0060041,0.012608109,0.999348519,2,36,retina development in camera-type eye,BP,420,125.7549327,1.018044844,0.266038833,3.826677608,0.000129884,0.0402567,CvsT2
95,Mcavernosa11724,GO:0032218,0.019211729,0.999862751,1,4,riboflavin transport,BP,407,437.7655515,-0.688347848,0.172144528,-3.998662383,6.37E-05,0.046691844,CvsT4
68,Mcavernosa03157,GO:0007606,0.016289886,0.999901447,1,4,sensory perception of chemical stimulus,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
67,Mcavernosa03157,GO:0050975,0.029285013,0.99963434,1,7,sensory perception of touch,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
64,Mcavernosa03157,GO:0050893,0.034578607,0.999478596,1,8,sensory processing,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
306,Mcavernosa24806,GO:0007525,0.011051174,0.99995976,1,3,somatic muscle development,BP,4855,1104.845015,-0.991656755,0.260593418,-3.805379137,0.000141587,0.041178809,CvsT2
310,Mcavernosa24806,GO:0030587,0.030752658,0.999596537,1,7,sorocarp development,BP,4855,1104.845015,-0.991656755,0.260593418,-3.805379137,0.000141587,0.041178809,CvsT2
291,Mcavernosa22344,GO:0035093,0.024326431,0.999755125,1,6,"spermatogenesis, exchange of chromosomal proteins",BP,2456,180.7912741,-4.008289508,0.938384448,-4.271479047,1.94E-05,0.017345891,CvsT4
9,Mcavernosa01252,GO:0046203,0.004225595,1,1,1,spermidine catabolic process,BP,2403,60.05324819,-2.078152054,0.517408289,-4.016464558,5.91E-05,0.039662932,CvsT1
10,Mcavernosa01252,GO:0046203,0.004225595,1,1,1,spermidine catabolic process,BP,2403,60.05324819,-2.691997683,0.515444492,-5.222672325,1.76E-07,0.000245061,CvsT2
5,Mcavernosa01252,GO:0046208,0.004225595,1,1,1,spermine catabolic process,BP,2403,60.05324819,-2.078152054,0.517408289,-4.016464558,5.91E-05,0.039662932,CvsT1
6,Mcavernosa01252,GO:0046208,0.004225595,1,1,1,spermine catabolic process,BP,2403,60.05324819,-2.691997683,0.515444492,-5.222672325,1.76E-07,0.000245061,CvsT2
164,Mcavernosa15302,GO:0015918,0.032841677,0.99953948,1,7,sterol transport,BP,666,426.2322626,-5.344808043,1.281647396,-4.170264038,3.04E-05,0.01764079,CvsT3
137,Mcavernosa13005,GO:0039521,0.005654587,1,1,1,suppression by virus of host autophagy,BP,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
138,Mcavernosa13005,GO:0039521,0.005654587,1,1,1,suppression by virus of host autophagy,BP,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
42,Mcavernosa02968,GO:0035999,0.024185742,0.99976758,1,5,tetrahydrofolate interconversion,BP,1792,92.20757882,-2.385831049,0.624115958,-3.822736812,0.000131979,0.0402567,CvsT2
21,Mcavernosa01252,GO:1903602,0.004225595,1,1,1,thermospermine catabolic process,BP,2403,60.05324819,-2.078152054,0.517408289,-4.016464558,5.91E-05,0.039662932,CvsT1
22,Mcavernosa01252,GO:1903602,0.004225595,1,1,1,thermospermine catabolic process,BP,2403,60.05324819,-2.691997683,0.515444492,-5.222672325,1.76E-07,0.000245061,CvsT2
49,Mcavernosa03157,GO:0035669,0.009110924,0.999979495,1,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
258,Mcavernosa15503,GO:0007178,0.033629173,0.99951698,1,7,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
259,Mcavernosa15503,GO:0007178,0.033629173,0.99951698,1,7,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
252,Mcavernosa15503,GO:0003186,0.005289377,1,1,1,tricuspid valve morphogenesis,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
253,Mcavernosa15503,GO:0003186,0.005289377,1,1,1,tricuspid valve morphogenesis,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
296,Mcavernosa24249,GO:0006641,0.03877324,0.999333048,1,9,triglyceride metabolic process,BP,1319,69.55413765,-3.986139509,0.922782607,-4.319695105,1.56E-05,0.015242565,CvsT4
196,Mcavernosa15503,GO:0003223,0.024379728,0.999763818,1,5,ventricular compact myocardium morphogenesis,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
197,Mcavernosa15503,GO:0003223,0.024379728,0.999763818,1,5,ventricular compact myocardium morphogenesis,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
184,Mcavernosa15503,GO:0060412,0.042771719,0.999187139,1,9,ventricular septum morphogenesis,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
185,Mcavernosa15503,GO:0060412,0.042771719,0.999187139,1,9,ventricular septum morphogenesis,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
174,Mcavernosa15503,GO:0003222,0.022580629,0.99979754,1,5,ventricular trabecula myocardium morphogenesis,BP,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
175,Mcavernosa15503,GO:0003222,0.022580629,0.99979754,1,5,ventricular trabecula myocardium morphogenesis,BP,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
388,Mcavernosa30570,GO:0016032,0.02823049,0.999669701,1,6,viral process,BP,1260,54.09720952,3.419651689,0.554761631,6.164182048,7.08E-10,4.43E-06,CvsT2
389,Mcavernosa30570,GO:0016032,0.02823049,0.999669701,1,6,viral process,BP,1260,54.09720952,3.786712496,0.559207441,6.7715703,1.27E-11,4.06E-08,CvsT1
390,Mcavernosa30570,GO:0016032,0.02823049,0.999669701,1,6,viral process,BP,1260,54.09720952,3.770755151,0.562532125,6.70318189,2.04E-11,8.67E-08,CvsT3
391,Mcavernosa30570,GO:0016032,0.02823049,0.999669701,1,6,viral process,BP,1260,54.09720952,2.919238186,0.539884327,5.407154908,6.40E-08,0.000160161,CvsT4
290,Mcavernosa21617,GO:0005912,0.010302974,0.999522734,2,33,adherens junction,CC,420,125.7549327,1.018044844,0.266038833,3.826677608,0.000129884,0.0402567,CvsT2
352,Mcavernosa25973,GO:0005912,0.010302974,0.999522734,2,33,adherens junction,CC,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
353,Mcavernosa25973,GO:0005912,0.010302974,0.999522734,2,33,adherens junction,CC,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
1,Mcavernosa01252,GO:0048046,0.009217614,0.99997901,1,2,apoplast,CC,2403,60.05324819,-2.078152054,0.517408289,-4.016464558,5.91E-05,0.039662932,CvsT1
2,Mcavernosa01252,GO:0048046,0.009217614,0.99997901,1,2,apoplast,CC,2403,60.05324819,-2.691997683,0.515444492,-5.222672325,1.76E-07,0.000245061,CvsT2
334,Mcavernosa25973,GO:0044291,0.022525308,0.999798536,1,5,cell-cell contact zone,CC,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
335,Mcavernosa25973,GO:0044291,0.022525308,0.999798536,1,5,cell-cell contact zone,CC,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
315,Mcavernosa25968,GO:0097361,0.017506403,0.999898722,1,3,CIA complex,CC,330,232.260006,-3.394989178,0.698041114,-4.863594866,1.15E-06,0.001201334,CvsT2
318,Mcavernosa25973,GO:0098691,0.032318253,0.999554135,1,7,dopaminergic synapse,CC,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
319,Mcavernosa25973,GO:0098691,0.032318253,0.999554135,1,7,dopaminergic synapse,CC,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
35,Mcavernosa02339,GO:0005769,0.014625799,0.998291799,3,108,early endosome,CC,1231,129.019574,1.071517133,0.262199641,4.086646069,4.38E-05,0.018244336,CvsT2
308,Mcavernosa24806,GO:0005769,0.014625799,0.998291799,3,108,early endosome,CC,4855,1104.845015,-0.991656755,0.260593418,-3.805379137,0.000141587,0.041178809,CvsT2
326,Mcavernosa25973,GO:0005769,0.014625799,0.998291799,3,108,early endosome,CC,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
327,Mcavernosa25973,GO:0005769,0.014625799,0.998291799,3,108,early endosome,CC,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
194,Mcavernosa15503,GO:0009897,0.029453952,0.997581051,2,55,external side of plasma membrane,CC,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
195,Mcavernosa15503,GO:0009897,0.029453952,0.997581051,2,55,external side of plasma membrane,CC,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
344,Mcavernosa25973,GO:0009897,0.029453952,0.997581051,2,55,external side of plasma membrane,CC,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
345,Mcavernosa25973,GO:0009897,0.029453952,0.997581051,2,55,external side of plasma membrane,CC,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
342,Mcavernosa25973,GO:0016600,0.027739417,0.999681155,1,6,flotillin complex,CC,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
343,Mcavernosa25973,GO:0016600,0.027739417,0.999681155,1,6,flotillin complex,CC,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
162,Mcavernosa15302,GO:0009277,0.009197955,0.9999791,1,2,fungal-type cell wall,CC,666,426.2322626,-5.344808043,1.281647396,-4.170264038,3.04E-05,0.01764079,CvsT3
244,Mcavernosa15503,GO:1990712,0.005289377,1,1,1,HFE-transferrin receptor complex,CC,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
245,Mcavernosa15503,GO:1990712,0.005289377,1,1,1,HFE-transferrin receptor complex,CC,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
32,Mcavernosa02339,GO:0001772,0.03500846,0.999465463,1,8,immunological synapse,CC,1231,129.019574,1.071517133,0.262199641,4.086646069,4.38E-05,0.018244336,CvsT2
275,Mcavernosa18547,GO:0030027,0.038552729,0.996324313,2,65,lamellipodium,CC,2125,136.6696901,-2.18273819,0.424178073,-5.145806276,2.66E-07,0.000320485,CvsT2
276,Mcavernosa18547,GO:0030027,0.038552729,0.996324313,2,65,lamellipodium,CC,2125,136.6696901,-2.479373075,0.422286214,-5.871309529,4.32E-09,2.30E-05,CvsT4
277,Mcavernosa18547,GO:0030027,0.038552729,0.996324313,2,65,lamellipodium,CC,2125,136.6696901,-2.295514097,0.422600061,-5.431883025,5.58E-08,8.89E-05,CvsT1
278,Mcavernosa18547,GO:0030027,0.038552729,0.996324313,2,65,lamellipodium,CC,2125,136.6696901,-2.68666738,0.421568034,-6.37303392,1.85E-10,4.73E-07,CvsT3
356,Mcavernosa25973,GO:0030027,0.038552729,0.996324313,2,65,lamellipodium,CC,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
357,Mcavernosa25973,GO:0030027,0.038552729,0.996324313,2,65,lamellipodium,CC,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
317,Mcavernosa25968,GO:0071817,0.011806576,0.999965518,1,2,MMXD complex,CC,330,232.260006,-3.394989178,0.698041114,-4.863594866,1.15E-06,0.001201334,CvsT2
380,Mcavernosa29012,GO:0000786,0.042634936,0.999192372,1,9,nucleosome,CC,716,244.6172493,-1.170659109,0.282911843,-4.137893615,3.51E-05,0.019439523,CvsT3
36,Mcavernosa02620,GO:0043226,0.025512308,0.998062738,2,52,organelle,CC,1458,23.01444182,-2.782782023,0.610643265,-4.557132098,5.19E-06,0.003814831,CvsT2
288,Mcavernosa21617,GO:0043226,0.025512308,0.998062738,2,52,organelle,CC,420,125.7549327,1.018044844,0.266038833,3.826677608,0.000129884,0.0402567,CvsT2
3,Mcavernosa01252,GO:0009505,0.014385395,0.999931712,1,3,plant-type cell wall,CC,2403,60.05324819,-2.078152054,0.517408289,-4.016464558,5.91E-05,0.039662932,CvsT1
4,Mcavernosa01252,GO:0009505,0.014385395,0.999931712,1,3,plant-type cell wall,CC,2403,60.05324819,-2.691997683,0.515444492,-5.222672325,1.76E-07,0.000245061,CvsT2
57,Mcavernosa03157,GO:0099523,0.049087065,0.998902728,1,11,presynaptic cytosol,CC,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
392,Mcavernosa30571,GO:0000502,0.030201637,0.999621664,1,6,proteasome complex,CC,684,48.83118655,4.512290209,0.623908042,7.232300119,4.75E-13,2.02E-09,CvsT1
393,Mcavernosa30571,GO:0000502,0.030201637,0.999621664,1,6,proteasome complex,CC,684,48.83118655,3.292573354,0.586079945,5.617959429,1.93E-08,3.45E-05,CvsT2
394,Mcavernosa30571,GO:0000502,0.030201637,0.999621664,1,6,proteasome complex,CC,684,48.83118655,3.02436151,0.576772448,5.243595667,1.57E-07,0.000328235,CvsT4
395,Mcavernosa30571,GO:0000502,0.030201637,0.999621664,1,6,proteasome complex,CC,684,48.83118655,3.975067304,0.605057227,6.56973775,5.04E-11,1.61E-07,CvsT3
292,Mcavernosa22344,GO:1990111,0.021631493,0.999814275,1,5,spermatoproteasome complex,CC,2456,180.7912741,-4.008289508,0.938384448,-4.271479047,1.94E-05,0.017345891,CvsT4
320,Mcavernosa25973,GO:0001931,0.017055801,0.999891927,1,4,uropod,CC,1008,229.2926542,-2.719399108,0.518128056,-5.248507729,1.53E-07,0.000239703,CvsT2
321,Mcavernosa25973,GO:0001931,0.017055801,0.999891927,1,4,uropod,CC,1008,229.2926542,2.726494755,0.522890109,5.214278698,1.85E-07,0.002353914,T2vsT3
28,Mcavernosa02339,GO:0071203,0.029235944,0.99964561,1,6,WASH complex,CC,1231,129.019574,1.071517133,0.262199641,4.086646069,4.38E-05,0.018244336,CvsT2
279,Mcavernosa18547,GO:0005545,0.044799139,0.999096549,1,10,1-phosphatidylinositol binding,MF,2125,136.6696901,-2.18273819,0.424178073,-5.145806276,2.66E-07,0.000320485,CvsT2
280,Mcavernosa18547,GO:0005545,0.044799139,0.999096549,1,10,1-phosphatidylinositol binding,MF,2125,136.6696901,-2.479373075,0.422286214,-5.871309529,4.32E-09,2.30E-05,CvsT4
281,Mcavernosa18547,GO:0005545,0.044799139,0.999096549,1,10,1-phosphatidylinositol binding,MF,2125,136.6696901,-2.295514097,0.422600061,-5.431883025,5.58E-08,8.89E-05,CvsT1
282,Mcavernosa18547,GO:0005545,0.044799139,0.999096549,1,10,1-phosphatidylinositol binding,MF,2125,136.6696901,-2.68666738,0.421568034,-6.37303392,1.85E-10,4.73E-07,CvsT3
73,Mcavernosa03157,GO:0003785,0.047256663,0.998993759,1,10,actin monomer binding,MF,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
283,Mcavernosa20093,GO:0008519,0.028021998,0.999674589,1,6,ammonium transmembrane transporter activity,MF,3467,234.587699,-0.762978102,0.192041569,-3.972984104,7.10E-05,0.0261073,CvsT2
139,Mcavernosa13005,GO:0019778,0.005654587,1,1,1,Atg12 activating enzyme activity,MF,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
140,Mcavernosa13005,GO:0019778,0.005654587,1,1,1,Atg12 activating enzyme activity,MF,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
135,Mcavernosa13005,GO:0019779,0.005654587,1,1,1,Atg8 activating enzyme activity,MF,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
136,Mcavernosa13005,GO:0019779,0.005654587,1,1,1,Atg8 activating enzyme activity,MF,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
377,Mcavernosa26093,GO:0004081,0.008121988,0.999983713,1,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,3092,62.8032388,-2.078882671,0.433108098,-4.799916415,1.59E-06,0.001419634,CvsT2
378,Mcavernosa26093,GO:0004081,0.008121988,0.999983713,1,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,3092,62.8032388,-2.005559371,0.432774224,-4.634193216,3.58E-06,0.003516066,CvsT3
379,Mcavernosa26093,GO:0004081,0.008121988,0.999983713,1,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,3092,62.8032388,-2.065820478,0.431381371,-4.788849538,1.68E-06,0.002377438,CvsT1
236,Mcavernosa15503,GO:0036122,0.009746732,0.999976525,1,2,BMP binding,MF,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
237,Mcavernosa15503,GO:0036122,0.009746732,0.999976525,1,2,BMP binding,MF,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
256,Mcavernosa15503,GO:0098821,0.005289377,1,1,1,BMP receptor activity,MF,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
257,Mcavernosa15503,GO:0098821,0.005289377,1,1,1,BMP receptor activity,MF,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
47,Mcavernosa03157,GO:0004698,0.021544192,0.999815778,1,5,calcium-dependent protein kinase C activity,MF,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
63,Mcavernosa03157,GO:0004699,0.009110924,0.999979495,1,2,calcium-independent protein kinase C activity,MF,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
40,Mcavernosa02968,GO:0047865,0.014805923,0.999927647,1,3,dimethylglycine dehydrogenase activity,MF,1792,92.20757882,-2.385831049,0.624115958,-3.822736812,0.000131979,0.0402567,CvsT2
266,Mcavernosa18489,GO:0016805,0.023729897,0.999776301,1,5,dipeptidase activity,MF,1295,18.39860871,-2.217050376,0.520136386,-4.262440457,2.02E-05,0.014007039,CvsT3
39,Mcavernosa02968,GO:0009055,0.010895455,0.99947965,2,34,electron transfer activity,MF,1792,92.20757882,-2.385831049,0.624115958,-3.822736812,0.000131979,0.0402567,CvsT2
92,Mcavernosa09510,GO:0009055,0.010895455,0.99947965,2,34,electron transfer activity,MF,1733,62.57618856,-1.087361575,0.27891717,-3.898510714,9.68E-05,0.047484759,CvsT3
50,Mcavernosa03157,GO:0035276,0.009110924,0.999979495,1,2,ethanol binding,MF,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
15,Mcavernosa01252,GO:0050660,0.030970754,0.997382278,2,59,flavin adenine dinucleotide binding,MF,2403,60.05324819,-2.078152054,0.517408289,-4.016464558,5.91E-05,0.039662932,CvsT1
16,Mcavernosa01252,GO:0050660,0.030970754,0.997382278,2,59,flavin adenine dinucleotide binding,MF,2403,60.05324819,-2.691997683,0.515444492,-5.222672325,1.76E-07,0.000245061,CvsT2
41,Mcavernosa02968,GO:0050660,0.030970754,0.997382278,2,59,flavin adenine dinucleotide binding,MF,1792,92.20757882,-2.385831049,0.624115958,-3.822736812,0.000131979,0.0402567,CvsT2
43,Mcavernosa02968,GO:0005542,0.020048352,0.999850483,1,4,folic acid binding,MF,1792,92.20757882,-2.385831049,0.624115958,-3.822736812,0.000131979,0.0402567,CvsT2
297,Mcavernosa24249,GO:0004370,0.00504164,1,1,1,glycerol kinase activity,MF,1319,69.55413765,-3.986139509,0.922782607,-4.319695105,1.56E-05,0.015242565,CvsT4
371,Mcavernosa26093,GO:0004820,0.00377484,1,1,1,glycine-tRNA ligase activity,MF,3092,62.8032388,-2.078882671,0.433108098,-4.799916415,1.59E-06,0.001419634,CvsT2
372,Mcavernosa26093,GO:0004820,0.00377484,1,1,1,glycine-tRNA ligase activity,MF,3092,62.8032388,-2.005559371,0.432774224,-4.634193216,3.58E-06,0.003516066,CvsT3
373,Mcavernosa26093,GO:0004820,0.00377484,1,1,1,glycine-tRNA ligase activity,MF,3092,62.8032388,-2.065820478,0.431381371,-4.788849538,1.68E-06,0.002377438,CvsT1
299,Mcavernosa24709,GO:0019001,0.037045375,0.999400974,1,8,guanyl nucleotide binding,MF,1200,328.9051022,-2.190398665,0.48942659,-4.475438625,7.63E-06,0.006769312,CvsT1
300,Mcavernosa24709,GO:0019001,0.037045375,0.999400974,1,8,guanyl nucleotide binding,MF,1200,328.9051022,-2.555606716,0.48911533,-5.224957304,1.74E-07,0.000246893,CvsT3
301,Mcavernosa24709,GO:0019001,0.037045375,0.999400974,1,8,guanyl nucleotide binding,MF,1200,328.9051022,-2.068522816,0.489967053,-4.221759001,2.42E-05,0.012631227,CvsT2
82,Mcavernosa03628,GO:0005085,0.005543269,0.999548951,3,76,guanyl-nucleotide exchange factor activity,MF,1737,40.74486054,-3.563927207,0.791478035,-4.502875695,6.70E-06,0.006769312,CvsT1
83,Mcavernosa03628,GO:0005085,0.005543269,0.999548951,3,76,guanyl-nucleotide exchange factor activity,MF,1737,40.74486054,-3.231938334,0.79422058,-4.069320809,4.72E-05,0.019021379,CvsT2
267,Mcavernosa18547,GO:0005085,0.005543269,0.999548951,3,76,guanyl-nucleotide exchange factor activity,MF,2125,136.6696901,-2.18273819,0.424178073,-5.145806276,2.66E-07,0.000320485,CvsT2
268,Mcavernosa18547,GO:0005085,0.005543269,0.999548951,3,76,guanyl-nucleotide exchange factor activity,MF,2125,136.6696901,-2.479373075,0.422286214,-5.871309529,4.32E-09,2.30E-05,CvsT4
269,Mcavernosa18547,GO:0005085,0.005543269,0.999548951,3,76,guanyl-nucleotide exchange factor activity,MF,2125,136.6696901,-2.295514097,0.422600061,-5.431883025,5.58E-08,8.89E-05,CvsT1
270,Mcavernosa18547,GO:0005085,0.005543269,0.999548951,3,76,guanyl-nucleotide exchange factor activity,MF,2125,136.6696901,-2.68666738,0.421568034,-6.37303392,1.85E-10,4.73E-07,CvsT3
314,Mcavernosa24806,GO:0005085,0.005543269,0.999548951,3,76,guanyl-nucleotide exchange factor activity,MF,4855,1104.845015,-0.991656755,0.260593418,-3.805379137,0.000141587,0.041178809,CvsT2
23,Mcavernosa01732,GO:0043167,0.017507186,0.997810703,3,117,ion binding,MF,4318,117.0658373,-1.794675121,0.434206367,-4.13323078,3.58E-05,0.015425471,CvsT2
163,Mcavernosa15302,GO:0043167,0.017507186,0.997810703,3,117,ion binding,MF,666,426.2322626,-5.344808043,1.281647396,-4.170264038,3.04E-05,0.01764079,CvsT3
382,Mcavernosa30410,GO:0043167,0.017507186,0.997810703,3,117,ion binding,MF,2360,67.87413264,-4.840038259,1.177933367,-4.108923639,3.98E-05,0.031070178,CvsT4
30,Mcavernosa02339,GO:0035255,0.033933704,0.99949799,1,8,ionotropic glutamate receptor binding,MF,1231,129.019574,1.071517133,0.262199641,4.086646069,4.38E-05,0.018244336,CvsT2
19,Mcavernosa01252,GO:0052904,0.004225595,1,1,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,2403,60.05324819,-2.078152054,0.517408289,-4.016464558,5.91E-05,0.039662932,CvsT1
20,Mcavernosa01252,GO:0052904,0.004225595,1,1,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,2403,60.05324819,-2.691997683,0.515444492,-5.222672325,1.76E-07,0.000245061,CvsT2
11,Mcavernosa01252,GO:0052903,0.004225595,1,1,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,2403,60.05324819,-2.078152054,0.517408289,-4.016464558,5.91E-05,0.039662932,CvsT1
12,Mcavernosa01252,GO:0052903,0.004225595,1,1,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,2403,60.05324819,-2.691997683,0.515444492,-5.222672325,1.76E-07,0.000245061,CvsT2
400,Mcavernosa30572,GO:0008137,0.00263302,0.999942334,2,17,NADH dehydrogenase (ubiquinone) activity,MF,1005,80.83542411,2.536921528,0.426786258,5.944243711,2.78E-09,2.30E-05,CvsT4
401,Mcavernosa30572,GO:0008137,0.00263302,0.999942334,2,17,NADH dehydrogenase (ubiquinone) activity,MF,1005,80.83542411,2.621084843,0.42831687,6.11949944,9.39E-10,1.71E-06,CvsT3
402,Mcavernosa30572,GO:0008137,0.00263302,0.999942334,2,17,NADH dehydrogenase (ubiquinone) activity,MF,1005,80.83542411,2.52336795,0.428497658,5.888872207,3.89E-09,1.34E-05,CvsT2
403,Mcavernosa30572,GO:0008137,0.00263302,0.999942334,2,17,NADH dehydrogenase (ubiquinone) activity,MF,1005,80.83542411,2.454734168,0.424001941,5.789440873,7.06E-09,1.50E-05,CvsT1
412,Mcavernosa30573,GO:0008137,0.00263302,0.999942334,2,17,NADH dehydrogenase (ubiquinone) activity,MF,849,48.37751756,2.429376336,0.425734667,5.706315517,1.15E-08,2.41E-05,CvsT2
413,Mcavernosa30573,GO:0008137,0.00263302,0.999942334,2,17,NADH dehydrogenase (ubiquinone) activity,MF,849,48.37751756,2.642152981,0.425552326,6.208761701,5.34E-10,1.36E-06,CvsT1
414,Mcavernosa30573,GO:0008137,0.00263302,0.999942334,2,17,NADH dehydrogenase (ubiquinone) activity,MF,849,48.37751756,1.877006536,0.410691899,4.570351982,4.87E-06,0.007611554,CvsT4
415,Mcavernosa30573,GO:0008137,0.00263302,0.999942334,2,17,NADH dehydrogenase (ubiquinone) activity,MF,849,48.37751756,2.621605005,0.428284154,6.121181425,9.29E-10,1.71E-06,CvsT3
13,Mcavernosa01252,GO:0052894,0.004225595,1,1,1,norspermine:oxygen oxidoreductase activity,MF,2403,60.05324819,-2.078152054,0.517408289,-4.016464558,5.91E-05,0.039662932,CvsT1
14,Mcavernosa01252,GO:0052894,0.004225595,1,1,1,norspermine:oxygen oxidoreductase activity,MF,2403,60.05324819,-2.691997683,0.515444492,-5.222672325,1.76E-07,0.000245061,CvsT2
294,Mcavernosa22344,GO:0016504,0.034065801,0.999494048,1,8,peptidase activator activity,MF,2456,180.7912741,-4.008289508,0.938384448,-4.271479047,1.94E-05,0.017345891,CvsT4
222,Mcavernosa15503,GO:0019211,0.022081999,0.999818453,1,4,phosphatase activator activity,MF,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
223,Mcavernosa15503,GO:0019211,0.022081999,0.999818453,1,4,phosphatase activator activity,MF,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
17,Mcavernosa01252,GO:0046592,0.009217614,0.99997901,1,2,polyamine oxidase activity,MF,2403,60.05324819,-2.078152054,0.517408289,-4.016464558,5.91E-05,0.039662932,CvsT1
18,Mcavernosa01252,GO:0046592,0.009217614,0.99997901,1,2,polyamine oxidase activity,MF,2403,60.05324819,-2.691997683,0.515444492,-5.222672325,1.76E-07,0.000245061,CvsT2
96,Mcavernosa11724,GO:0032217,0.019211729,0.999862751,1,4,riboflavin transmembrane transporter activity,MF,407,437.7655515,-0.688347848,0.172144528,-3.998662383,6.37E-05,0.046691844,CvsT4
62,Mcavernosa03157,GO:0030546,0.013898772,0.999936268,1,3,signaling receptor activator activity,MF,1357,267.0719039,-2.306681698,0.549281471,-4.19945296,2.68E-05,0.013384452,CvsT2
24,Mcavernosa01732,GO:0036094,0.035078687,0.999463301,1,8,small molecule binding,MF,4318,117.0658373,-1.794675121,0.434206367,-4.13323078,3.58E-05,0.015425471,CvsT2
159,Mcavernosa14558,GO:0015299,0.017522074,0.999885914,1,4,solute:proton antiporter activity,MF,2414,149.1954136,-1.050650348,0.218054927,-4.818283008,1.45E-06,0.001539212,CvsT3
160,Mcavernosa14558,GO:0015299,0.017522074,0.999885914,1,4,solute:proton antiporter activity,MF,2414,149.1954136,-0.948452579,0.218745521,-4.335871991,1.45E-05,0.015242565,CvsT4
161,Mcavernosa14558,GO:0015299,0.017522074,0.999885914,1,4,solute:proton antiporter activity,MF,2414,149.1954136,-1.029002693,0.219041739,-4.697747088,2.63E-06,0.002193109,CvsT2
7,Mcavernosa01252,GO:0052901,0.004225595,1,1,1,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,2403,60.05324819,-2.078152054,0.517408289,-4.016464558,5.91E-05,0.039662932,CvsT1
8,Mcavernosa01252,GO:0052901,0.004225595,1,1,1,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,2403,60.05324819,-2.691997683,0.515444492,-5.222672325,1.76E-07,0.000245061,CvsT2
178,Mcavernosa15503,GO:0005025,0.01439422,0.999931628,1,3,"transforming growth factor beta receptor activity, type I",MF,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
179,Mcavernosa15503,GO:0005025,0.01439422,0.999931628,1,3,"transforming growth factor beta receptor activity, type I",MF,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
228,Mcavernosa15503,GO:0004675,0.009746732,0.999976525,1,2,transmembrane receptor protein serine/threonine kinase activity,MF,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
229,Mcavernosa15503,GO:0004675,0.009746732,0.999976525,1,2,transmembrane receptor protein serine/threonine kinase activity,MF,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
129,Mcavernosa13005,GO:0008641,0.014598678,0.999929665,1,3,ubiquitin-like modifier activating enzyme activity,MF,597,53.9311192,1.258737966,0.291603628,4.316605988,1.58E-05,0.015242565,CvsT4
130,Mcavernosa13005,GO:0008641,0.014598678,0.999929665,1,3,ubiquitin-like modifier activating enzyme activity,MF,597,53.9311192,1.240011733,0.291394178,4.255444439,2.09E-05,0.014007039,CvsT3
420,Mcavernosa33068,GO:0099635,0.02031177,0.999846511,1,4,voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels,MF,1118,45.86133265,-1.046864772,0.262721652,-3.984691651,6.76E-05,0.0261073,CvsT2
38,Mcavernosa02621,GO:0005244,0.035698329,0.999444038,1,8,voltage-gated ion channel activity,MF,2097,43.78461537,-4.291359851,0.949815485,-4.51809843,6.24E-06,0.004335238,CvsT2
192,Mcavernosa15503,GO:0140537,0.024226068,0.9997668,1,5,NA,NA,1002,41.66980663,-2.09934597,0.47427835,-4.426400594,9.58E-06,0.008148406,CvsT3
193,Mcavernosa15503,GO:0140537,0.024226068,0.9997668,1,5,NA,NA,1002,41.66980663,-1.847841721,0.478265041,-3.863635357,0.000111712,0.036764989,CvsT2
384,Mcavernosa30570,GO:0140640,0.047385992,0.998988193,1,10,NA,NA,1260,54.09720952,3.419651689,0.554761631,6.164182048,7.08E-10,4.43E-06,CvsT2
385,Mcavernosa30570,GO:0140640,0.047385992,0.998988193,1,10,NA,NA,1260,54.09720952,3.786712496,0.559207441,6.7715703,1.27E-11,4.06E-08,CvsT1
386,Mcavernosa30570,GO:0140640,0.047385992,0.998988193,1,10,NA,NA,1260,54.09720952,3.770755151,0.562532125,6.70318189,2.04E-11,8.67E-08,CvsT3
387,Mcavernosa30570,GO:0140640,0.047385992,0.998988193,1,10,NA,NA,1260,54.09720952,2.919238186,0.539884327,5.407154908,6.40E-08,0.000160161,CvsT4